BioSpace News Archive

Drug Development

Human Genome Sciences, Inc. Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C

November 5, 2007
·
8 min read
Drug Development

Phase 2 Trial Results for Exelixis, Inc.’ XL784 Presented at the 2007 American Society of Nephrology Conference

November 5, 2007
·
5 min read
Drug Development

Keryx Biopharmaceuticals Announces Positive Preliminary Phase 2 Data on KRX-0401

November 5, 2007
·
7 min read
Drug Development

Positive Results From Peregrine Pharmaceuticals, Inc.'s Bavituximab Phase l HCV Trial Presented at AASLD Meeting

November 5, 2007
·
6 min read
Drug Development

Daiichi Sankyo, Inc. and Eli Lilly and Company Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel

November 5, 2007
·
5 min read
Drug Development

Medivation, Inc.'s MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial

November 5, 2007
·
5 min read
Drug Development

FDA Approves Epeius Biotechnologies Corporation’s Opening of Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma

November 5, 2007
·
3 min read
Drug Development

Eli Lilly and Company In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack

November 5, 2007
·
9 min read
Business

Cardinal Health, Inc. Reports First Quarter Results

November 5, 2007
·
4 min read
Drug Development

Sangamo BioSciences, Inc. Presents Postive Data Showing Pain Reduction by Novel ZFP Therapeutic

November 5, 2007
·
6 min read